AFIX to Improve HPV Vaccination
NCT02370459 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 223
Last updated 2017-02-24
Summary
The University of North Carolina will test the effectiveness of the Centers for Disease Control and Prevention's AFIX model for increasing HPV vaccination coverage among adolescents. AFIX (Assessment, Feedback, Incentives and eXchange) consists of brief quality improvement consultations that immunization specialists from state health departments deliver to vaccine providers in primary care settings. Using immunization registry data, the specialist evaluates the clinic's vaccination coverage and delivers education on best practices to improve coverage. We will compare changes in HPV vaccination coverage before and after consultations for high-volume pediatric and family medicine clinics across three study conditions: traditional consultations (in-person group), virtual consultations (webinar group), or no consultations (control group). In each participating state, 30 clinics will be randomly assigned to each study arm, for a total of 90 clinics per state, or 270 clinics overall. The primary objective of this study is to compare the change in coverage for HPV vaccine initiation among 11-12 year old patients, from baseline to 6-month follow-up. Secondarily, we will compare the change in coverage for other vaccines and age groups.
Conditions
- Papillomavirus Vaccines
- Adolescent Health Services
Interventions
- OTHER
-
AFIX in-person consultation
The adolescent AFIX (Assessment, Feedback, Incentives, and eXchange) Program is a quality improvement strategy developed by the CDC to improve the immunization practices and vaccination coverage levels of public and private health care providers. It has four main components: 1) Assessment of a provider's current immunization practices and vaccination levels, 2) Feedback of the assessment results and strategies to improve coverage levels, 3) Incentives to improve coverage levels, and 4) eXchange of information and resources necessary to facilitate improvement. Relevant AFIX information will be communicated to vaccine providers using several intervention and quality improvement components.
- OTHER
-
AFIX webinar consultation
The adolescent AFIX (Assessment, Feedback, Incentives, and eXchange) Program is a quality improvement strategy developed by the CDC to improve the immunization practices and vaccination coverage levels of public and private health care providers. It has four main components: 1) Assessment of a provider's current immunization practices and vaccination levels, 2) Feedback of the assessment results and strategies to improve coverage levels, 3) Incentives to improve coverage levels, and 4) eXchange of information and resources necessary to facilitate improvement. Relevant AFIX information will be communicated to vaccine providers using several intervention and quality improvement components.
Sponsors & Collaborators
-
Robert Wood Johnson Foundation
collaborator OTHER -
Washington State, Department of Health
collaborator OTHER_GOV -
Illinois Department of Public Health
collaborator OTHER -
Michigan Department of Community Health
collaborator OTHER -
Harvard Medical School (HMS and HSDM)
collaborator OTHER -
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Melissa B Gilkey, PhD · Harvard Medical School (HMS and HSDM)
-
Noel T Brewer, PhD · University of North Carolina
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2016-11-30
- Completion
- 2016-11-30
Countries
- United States
Study Locations
More Related Trials
-
State Immunization Information Systems to Improve HPV Vaccination Rates
NCT02993965 ·Status: COMPLETED ·Phase: NA
-
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
NCT04722822 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates
NCT01526551 ·Status: COMPLETED ·Phase: NA
-
The STOP-HPV Trial 2: Performance Feedback Intervention
NCT03599570 ·Status: COMPLETED ·Phase: NA
-
PREVENT Pilot HPV - Related Cancers Trial
NCT06738355 ·Status: COMPLETED ·Phase: NA
-
Electronic Messaging to Increase Human Papillomavirus Vaccine Utilization and Adherence Among College Students
NCT01568515 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
HPV IIS Reminder/Recall- New York State
NCT03057379 ·Status: COMPLETED ·Phase: NA
-
PREVENT HPV -Related Cancers Trial
NCT07217145 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The STOP-HPV Trial 3: Prompts Intervention
NCT03599583 ·Status: UNKNOWN ·Phase: NA
-
Improving HPV Vaccination Rates Among Rural and Native American Adolescents
NCT03801603 ·Status: COMPLETED ·Phase: NA
-
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
NCT05006833 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Human Papilloma Viruses (HPV) Vaccine Adherence Community Clinic Study
NCT01908517 ·Status: COMPLETED ·Phase: NA
-
Educational Intervention to Minimize Disparities in Humanpapillomavirus Vaccination
NCT02145156 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination
NCT03628885 ·Status: COMPLETED ·Phase: NA
-
Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial
NCT03429413 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
SDH of HPV Vaccine Completion
NCT03709602 ·Status: COMPLETED
-
Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacies
NCT05831540 ·Status: TERMINATED ·Phase: NA
-
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults
NCT04474821 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
NCT06243666 ·Status: ACTIVE_NOT_RECRUITING
-
Effectiveness of HPV Vaccine Among Adolescents and Reproductive Women
NCT06220747 ·Status: RECRUITING
-
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
NCT07104240 ·Status: RECRUITING ·Phase: NA
-
Immunogenicity of Fractional Dose of the HPV Vaccines
NCT05291871 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV
NCT07303751 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Facilitating Completion of HPV Vaccination
NCT01600560 ·Status: COMPLETED
-
Patient Decision Aid Tool for HPV Vaccination Among Adults Ages 27-45 Years Old
NCT06435338 ·Status: COMPLETED ·Phase: NA